doi:10.1016/j.cld.2013.07.002 [PMC Full Text] [PubMed] [Crosslink] 61
Peng X., Luo Z., He S., Zhang L., and Li Y., BloodBrain Barrier Disruption by Lipopolysaccharide and SepsisAssociated Encephalopathy, Frontiers in Cellular and Infection Microbiology 11 (2021): 768108, 10.3389/fcimb.2021.768108
It is FDA-approved for use by UAE medical professionals for reducing visceral fat in HIV-associated lipodystrophy but is also explored for its potential benefits in fat loss, muscle preservation, and cognitive function
Mechanism of action Semax works primarily through modulation of neurotrophic factors that determine neuronal health and plasticity
SantosMCOliveiraALViegas-CrespoAMVicenteLBarreirosAMonteiroPet alSystemic markers of the redox balance in chronic obstructive pulmonary disease